SAM
CTSO icon

Seelaus Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Seelaus Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.1K Hold
16,300
– – ﹤0.01% 204
2026
Q1 		$9.23K Sell
16,300
-1,000
-6% -$683 0.01% 203
2025
Q4 		$11.1K Hold
17,300
– – 0.01% 174
2025
Q3 		$16.2K Sell
17,300
-1,000
-5% -$985 0.01% 180
2025
Q2 		$23.4K Hold
18,300
– – 0.02% 175
2025
Q1 		$18.3K Sell
18,300
-500
-3% -$527 0.02% 170
2024
Q4 		$17.1K Hold
18,800
– – 0.02% 168
2024
Q3 		$28.2K Hold
18,800
– – 0.03% 171
2024
Q2 		$13.2K Sell
18,800
-150
-0.8% -$130 0.01% 171
2024
Q1 		$18K Hold
18,950
– – 0.02% 170
2023
Q4 		$21K Sell
18,950
-1,500
-7% -$2.23K 0.02% 180
2023
Q3 		$38.4K Hold
20,450
– – 0.04% 158
2023
Q2 		$73K Hold
20,450
– – 0.06% 184
2023
Q1 		$65K Hold
20,450
– – 0.05% 189
2022
Q4 		$32K Sell
20,450
-3,450
-14% -$5.12K 0.02% 196
2022
Q3 		$33K Hold
23,900
– – 0.03% 196
2022
Q2 		$52K Hold
23,900
– – 0.04% 205
2022
Q1 		$76K Hold
23,900
– – 0.05% 247
2021
Q4 		$100K Buy
23,900
+500
+2% +$2.81K 0.05% 250
2021
Q3 		$190K Buy
23,400
+500
+2% +$4.06K 0.11% 226
2021
Q2 		$173K Sell
22,900
-1,000
-4% -$8.43K 0.1% 238
2021
Q1 		$207K Buy
23,900
+1,200
+5% +$11.4K 0.13% 192
2020
Q4 		$181K Buy
22,700
+2,700
+14% +$22.6K 0.13% 176
2020
Q3 		$160K Buy
+20,000
New +$180K 0.13% 147

Other funds holding CTSO

KCFA
Key Client Fiduciary Advisors Fairfield, New Jersey $347M AUM 35.3% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Seelaus Asset Management's CTSO Position: Q2 2026 in Review

Seelaus Asset Management held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 16,300 shares worth $6.1K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Seelaus Asset Management first reported a position in CTSO in Q3 2020 and has held it in 24 quarters since. The position peaked at $207K in Q1 2021. 4 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Seelaus Asset Management held 16,300 shares of Cytosorbents Corp worth $6.1K as of Q2 2026.
  • Seelaus Asset Management left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of Seelaus Asset Management's portfolio in Q2 2026, its #204 holding.
  • Seelaus Asset Management first reported a position in Cytosorbents Corp in Q3 2020 and has held it in 24 quarters since.
  • Seelaus Asset Management's Cytosorbents Corp position peaked at $207K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.